Urogenital Neoplasms Clinical Trials

49 clinical trials for Urogenital Neoplasms across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies — RECRUITING
• Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection — RECRUITING · PHASE1
• Association Between the SPHERTEST in Vitro Test and Response to Checkpoint Inhibitor Treatments in Patients With Advanced or Metastatic Urothelial Carcinoma — RECRUITING
• CD70-targeted immunoPET Imaging of Kidney Cancer — RECRUITING · PHASE2
• Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer — RECRUITING · PHASE2
• Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma — RECRUITING
• 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer — RECRUITING · PHASE4
• Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer — RECRUITING · PHASE2
• Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations — ACTIVE_NOT_RECRUITING · PHASE1
• High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy — TERMINATED · PHASE2
• Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) — ACTIVE_NOT_RECRUITING · PHASE3
• Alkagin Paste in the Prevention of Radiation Dermatitis — TERMINATED · PHASE2
• Expanded Access to NanoDoce — TERMINATED
• Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) — TERMINATED · PHASE2
• Health Gatherings - For Your Health After Cancer — COMPLETED · NA
• Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy — ACTIVE_NOT_RECRUITING
• Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer — COMPLETED · PHASE1
• P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) — TERMINATED · PHASE1
• CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood — ACTIVE_NOT_RECRUITING · NA
• A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts — OTHER · PHASE2
• EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC — OTHER · PHASE2
• Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial — COMPLETED · NA
• Evaluation of NanoDoce® in Participants With Urothelial Carcinoma — COMPLETED · PHASE1
• Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment — COMPLETED
• Potential Therapeutic Response In Urogenital Tumors — COMPLETED
• Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer — COMPLETED · PHASE2
• Trial of NanoPac Focal Therapy for Prostate Cancer — TERMINATED · PHASE2
• 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical — OTHER · NA
• Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma — OTHER · PHASE2
• Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) — OTHER · PHASE1
• Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma — OTHER · PHASE2
• Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer — OTHER · PHASE2
• Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer — OTHER · PHASE2
• Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed — OTHER · NA
• A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer — TERMINATED · PHASE2
• A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma — TERMINATED · PHASE1
• A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer — TERMINATED · PHASE1
• Protection of Rectum From High Radiation Doses Using a Spacer — TERMINATED · NA
• Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy — COMPLETED · PHASE2
• Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer — OTHER
• Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients — COMPLETED · NA
• Acupuncture for the Immune System in Radiation Cancer Patients — WITHDRAWN · PHASE3
• SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I — WITHDRAWN · PHASE3
• Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients — COMPLETED
• A Trial for Patients With Advanced/Recurrent Endometrial Cancer — COMPLETED · PHASE2
• Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer — COMPLETED · PHASE2

Refine this search